Skip to content
TrackPodcasts
healthJan 2, 202650:23pending

Bioidentical V.S. Non-Bioidentical Hormones

About this episode

James O'Hara sits down with Dr Dan Bristow (OB-GYN) to talk about hormones


For High-quality labs:


► http://sagebio.com/



For information on the Gillett Health clinic, lab panels, and health coaching:


► https://GillettHealth.com



Follow Gillett Health for more content from James and Kyle


► https://instagram.com/gilletthealth


► https://www.tiktok.com/@gilletthealth


► https://twitter.com/gilletthealth


► https://www.facebook.com/gilletthealth



Follow Kyle Gillett, MD


► https://instagram.com/kylegillettmd



Follow James O’Hara, NP


► https://Instagram.com/jamesoharanp



For 10% off Gorilla Mind products, including SIGMA: Use code “GH10”


► https://gorillamind.com/



For discounts on high-quality supplements


►https://www.thorne.com/u/GillettHealth



►Compiled Source List


Systematic and Narrative Reviews

1. Gut microbial β‑glucuronidase: a vital regulator in female estrogen metabolism and gynecologic cancers

PMCID: PMC10416750

• Year: 2023

• Journal: International Journal of Molecular Sciences

• Summary: Reviews role of β-glucuronidase in estrogen metabolism, breast cancer, endometriosis.

2. A New Paradigm in Gut Microbiota & Breast Cancer: β‑Glucuronidase as Therapeutic Target

DOI: 10.3390/pathogens12091086

• Year: 2023

• Journal: Pathogens

• Summary: Emerging model proposing gmGUS as a direct target in estrogen-driven breast cancer.

3. Gut and oral microbiota in gynecologic cancers: mechanisms and therapeutic value

DOI: 10.1038/s41522-024-00577-7

• Year: 2024

• Journal: npj Biofilms and Microbiomes

• Summary: Systematic review on microbiota’s role in ovarian, cervical, and breast cancers.


Human Clinical or Case-Control Studies

4. Assessment of gut microbial β‑glucuronidase and β‑glucosidase activity in women with PCOS

PMCID: PMC10366212

• Year: 2023

• Journal: Scientific Reports

• Summary: Found significantly higher β-glucuronidase activity in PCOS patients.

5. Gut microbiota and ovarian diseases: a new therapeutic perspective

DOI: 10.1186/s13048-025-01684-5

• Year: 2025

• Journal: Journal of Ovarian Research

• Summary: Review covering PCOS, POI, and tumors—describes estrogen recycling via gut microbiota.


Mechanistic, In Vitro, and Animal Studies

6. In vitro analysis of gut microbial β‑glucuronidases and estrogen deconjugation

DOI: 10.1016/j.jbc.2020.105542

• Year: 2020

• Journal: Journal of Biological Chemistry

• Summary: Characterized 35 GUS enzymes that reactivate estrogen glucuronides.

7. Impact of intestinal flora on ovarian function and disease pathogenesis

Full text: e-century.us

• Year: 2024

• Journal: American Journal of Translational Research

• Summary: Animal studies showing how β-G-producing gut bacteria drive ovarian dysfunction.

8. The role of gut microbiota in endometriosis: current insights

DOI: 10.3389/fmicb.2024.1363455

• Year: 2024

• Journal: Frontiers in Microbiology

• Summary: Mechanistic review linking β-G-producing bacteria to lesion development and inflammation in endometriosis.



#female #femalehealth #hormones #testosterone



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

Get every episode summarized

Each time The Gillett Health Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Bioidentical V.S. Non-Bioidentical Hormones

The Gillett Health Podcast

0:00
50:23

More episodes

More from The Gillett Health Podcast

View all episodes →